Urinary biomarkers of kidney transplant rejection.

Despite the introduction of many new immunosuppressive medications, allograft rejection remains a significant complication in transplantation. A contributing factor could be poor study design or quality of biospecimen repositories.

⚡ This is an original paraphrased summary — not copied from the abstract. Full paper available at the source link below.

• 1 The use of "liquid biopsy" to evaluate allograft function and detect early rejection has recently become a prominent focus of investigation as it holds promise in providing noninvasive and immediate insights into the cellular and molecular makeup of the graft.
• 2 In recent years, the introduction of molecular medicine along with the use of new technologies, including high-throughput techniques, has not only accelerated biomarker discovery but has also contributed to improving our understanding of the mechanisms underlying immune rejection.
• 3 Genomics, transcriptomics, and metabolomics approaches, along with the increasing use of machine learning techniques, have paved the way for the discovery and development of novel biomarkers.

Understanding this could lead to better treatments, improved diagnostics, or a deeper grasp of how the human body works — benefiting patient care globally.

This summary is based on publicly available metadata and abstract. For the full research paper, visit the original source: